BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

542 related articles for article (PubMed ID: 29258545)

  • 1. Dendrimer-mediated delivery of N-acetyl cysteine to microglia in a mouse model of Rett syndrome.
    Nance E; Kambhampati SP; Smith ES; Zhang Z; Zhang F; Singh S; Johnston MV; Kannan RM; Blue ME; Kannan S
    J Neuroinflammation; 2017 Dec; 14(1):252. PubMed ID: 29258545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dendrimer nanotherapy targeting of glial dysfunction improves inflammation and neurobehavioral phenotype in adult female Mecp2-heterozygous mouse model of Rett syndrome.
    Khoury ES; Patel RV; O'Ferrall C; Fowler A; Sah N; Sharma A; Gupta S; Scafidi S; Kurtz JS; Olmstead SJ; Kudchadkar SR; Kannan RM; Blue ME; Kannan S
    J Neurochem; 2024 May; 168(5):841-854. PubMed ID: 37777475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome.
    Khoury ES; Sharma A; Ramireddy RR; Thomas AG; Alt J; Fowler A; Rais R; Tsukamoto T; Blue ME; Slusher B; Kannan S; Kannan RM
    Theranostics; 2020; 10(13):5736-5748. PubMed ID: 32483415
    [No Abstract]   [Full Text] [Related]  

  • 4. Rett syndrome microglia damage dendrites and synapses by the elevated release of glutamate.
    Maezawa I; Jin LW
    J Neurosci; 2010 Apr; 30(15):5346-56. PubMed ID: 20392956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
    Wang B; Navath RS; Romero R; Kannan S; Kannan R
    Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wild-type microglia arrest pathology in a mouse model of Rett syndrome.
    Derecki NC; Cronk JC; Lu Z; Xu E; Abbott SB; Guyenet PG; Kipnis J
    Nature; 2012 Mar; 484(7392):105-9. PubMed ID: 22425995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Mitochondrial Dysfunction and Oxidative Stress in Activated Microglia using Dendrimer-Based Therapeutics.
    Sharma A; Liaw K; Sharma R; Zhang Z; Kannan S; Kannan RM
    Theranostics; 2018; 8(20):5529-5547. PubMed ID: 30555562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the possible link between MeCP2 and oxidative stress in Rett syndrome.
    Filosa S; Pecorelli A; D'Esposito M; Valacchi G; Hajek J
    Free Radic Biol Med; 2015 Nov; 88(Pt A):81-90. PubMed ID: 25960047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative brain damage in Mecp2-mutant murine models of Rett syndrome.
    De Felice C; Della Ragione F; Signorini C; Leoncini S; Pecorelli A; Ciccoli L; Scalabrì F; Marracino F; Madonna M; Belmonte G; Ricceri L; De Filippis B; Laviola G; Valacchi G; Durand T; Galano JM; Oger C; Guy A; Bultel-Poncé V; Guy J; Filosa S; Hayek J; D'Esposito M
    Neurobiol Dis; 2014 Aug; 68(100):66-77. PubMed ID: 24769161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RIPK1 activation in Mecp2-deficient microglia promotes inflammation and glutamate release in RTT.
    Cao Z; Min X; Xie X; Huang M; Liu Y; Sun W; Xu G; He M; He K; Li Y; Yuan J
    Proc Natl Acad Sci U S A; 2024 Feb; 121(6):e2320383121. PubMed ID: 38289948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptome analysis of microglia in a mouse model of Rett syndrome: differential expression of genes associated with microglia/macrophage activation and cellular stress.
    Zhao D; Mokhtari R; Pedrosa E; Birnbaum R; Zheng D; Lachman HM
    Mol Autism; 2017; 8():17. PubMed ID: 28367307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alterations of gene expression and glutamate clearance in astrocytes derived from an MeCP2-null mouse model of Rett syndrome.
    Okabe Y; Takahashi T; Mitsumasu C; Kosai K; Tanaka E; Matsuishi T
    PLoS One; 2012; 7(4):e35354. PubMed ID: 22532851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.
    Mishra MK; Beaty CA; Lesniak WG; Kambhampati SP; Zhang F; Wilson MA; Blue ME; Troncoso JC; Kannan S; Johnston MV; Baumgartner WA; Kannan RM
    ACS Nano; 2014 Mar; 8(3):2134-47. PubMed ID: 24499315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model.
    Zhang Z; Lin YA; Kim SY; Su L; Liu J; Kannan RM; Kannan S
    J Neuroinflammation; 2020 Oct; 17(1):319. PubMed ID: 33100217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of glutamine transporter SNAT1 in Rett syndrome microglia: a mechanism for mitochondrial dysfunction and neurotoxicity.
    Jin LW; Horiuchi M; Wulff H; Liu XB; Cortopassi GA; Erickson JD; Maezawa I
    J Neurosci; 2015 Feb; 35(6):2516-29. PubMed ID: 25673846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological read-through of R294X Mecp2 in a novel mouse model of Rett syndrome.
    Merritt JK; Collins BE; Erickson KR; Dong H; Neul JL
    Hum Mol Genet; 2020 Aug; 29(15):2461-2470. PubMed ID: 32469049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain-derived neurotrophic factor expression and respiratory function improve after ampakine treatment in a mouse model of Rett syndrome.
    Ogier M; Wang H; Hong E; Wang Q; Greenberg ME; Katz DM
    J Neurosci; 2007 Oct; 27(40):10912-7. PubMed ID: 17913925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment with the Bacterial Toxin CNF1 Selectively Rescues Cognitive and Brain Mitochondrial Deficits in a Female Mouse Model of Rett Syndrome Carrying a MeCP2-Null Mutation.
    Urbinati C; Cosentino L; Germinario EAP; Valenti D; Vigli D; Ricceri L; Laviola G; Fiorentini C; Vacca RA; Fabbri A; De Filippis B
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
    Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
    Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomic analysis of the Rett syndrome experimental model mecp2
    Cortelazzo A; Pietri T; De Felice C; Leoncini S; Guerranti R; Signorini C; Timperio AM; Zolla L; Ciccoli L; Hayek J
    J Proteomics; 2017 Feb; 154():128-133. PubMed ID: 28062374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.